List of genome editing patents

Patents where

Current Assignee

Industry

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7195616 Medication injector apparatus with drive assembly that facilitates reset	Patent 7195616 was granted and assigned to Eli Lilly on March, 2007 by the United States Patent and Trademark Office.		Eli Lilly	United States Patent and Trademark Office	7195616	March 27, 2007
‌ US Patent 10011849 Nucleic acid-guided nucleases	Patent 10011849 was granted and assigned to Inscripta on July, 2018 by the United States Patent and Trademark Office.	Inscripta	Inscripta	United States Patent and Trademark Office	10011849	July 3, 2018
‌ US Patent 9220845 Medication injector apparatus with drive assembly that facilitates reset	Patent 9220845 was granted and assigned to Eli Lilly and Company on December, 2015 by the United States Patent and Trademark Office.	Eli Lilly	Eli Lilly	United States Patent and Trademark Office	9220845	December 29, 2015
‌ US Patent 9713503 Surgical utility connector	Patent 9713503 was granted and assigned to Novartis on July, 2017 by the United States Patent and Trademark Office.	Novartis	Novartis	United States Patent and Trademark Office	9713503	July 25, 2017
‌ US Patent 7384934 Piperazine substituted aryl benzodiazepines	Patent 7384934 was granted and assigned to Eli Lilly and Company on June, 2008 by the United States Patent and Trademark Office.		Eli Lilly	United States Patent and Trademark Office	7384934	June 10, 2008
‌ US Patent 7410996 3-aryloxy/thio-2,3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake	Patent 7410996 was granted and assigned to Eli Lilly and Company on August, 2008 by the United States Patent and Trademark Office.		Eli Lilly	United States Patent and Trademark Office	7410996	August 12, 2008
‌ US Patent 10072082 Cancer immunotherapy by disrupting PD-1/PD-L1 signaling	Patent 10072082 was granted and assigned to Bristol-Myers Squibb on September, 2018 by the United States Patent and Trademark Office.	Bristol-Myers Squibb	Bristol-Myers Squibb	United States Patent and Trademark Office	10072082	September 11, 2018
‌ US Patent 10485920 Needle unit with a lockable needle shield and an injection device comprising such a needle unit	Patent 10485920 was granted and assigned to Novo Nordisk on November, 2019 by the United States Patent and Trademark Office.	Novo Nordisk	Novo Nordisk	United States Patent and Trademark Office	10485920	November 26, 2019
‌ US Patent 7195623 Kit including side firing syringe needle for preparing a drug in an injection pen cartridge	Patent 7195623 was granted and assigned to Eli Lilly on March, 2007 by the United States Patent and Trademark Office.		Eli Lilly	United States Patent and Trademark Office	7195623	March 27, 2007
‌ US Patent 8409138 Delay mechanism for automatic injection device	Patent 8409138 was granted and assigned to Eli Lilly on April, 2013 by the United States Patent and Trademark Office.		Eli Lilly	United States Patent and Trademark Office	8409138	April 2, 2013
‌ US Patent 11642468 Medicament injection device with rotary encoder	Patent 11642468 was granted and assigned to Sanofi on May, 2023 by the United States Patent and Trademark Office.	Sanofi	Sanofi	United States Patent and Trademark Office	11642468	May 9, 2023
‌ US Patent 9072587 Surgical variable-angle illuminator	Patent 9072587 was granted and assigned to Novartis on July, 2015 by the United States Patent and Trademark Office.		Novartis	United States Patent and Trademark Office	9072587	July 7, 2015
‌ US Patent 7517546 Method for precipitating mono and multiple layers of organophosphoric and organophosphonic acids and the salts thereof in addition to use thereof	Patent 7517546 was granted and assigned to Bayer on April, 2009 by the United States Patent and Trademark Office.		Bayer	United States Patent and Trademark Office	7517546	April 14, 2009
‌ US Patent 6946079 Centrifugal filtration method for separating fibrin monomer from blood	Patent 6946079 was granted and assigned to Bristol-Myers Squibb on September, 2005 by the United States Patent and Trademark Office.		Bristol-Myers Squibb	United States Patent and Trademark Office	6946079	September 20, 2005
‌ US Patent 7332303 Product quality enhancement in mammalian cell culture processes for protein production	Patent 7332303 was granted and assigned to Bristol-Myers Squibb on February, 2008 by the United States Patent and Trademark Office.		Bristol-Myers Squibb	United States Patent and Trademark Office	7332303	February 19, 2008
‌ US Patent 8147728 Pad transfer printing of silicone hydrogel lenses using colored ink	Patent 8147728 was granted and assigned to Novartis on April, 2012 by the United States Patent and Trademark Office.		Novartis	United States Patent and Trademark Office	8147728	April 3, 2012
‌ US Patent 11650159 Method of predicting a performance characteristic of a plant or yeast hydrolysate and its use	Patent 11650159 was granted and assigned to Takeda Pharmaceutical Company on May, 2023 by the United States Patent and Trademark Office.	Takeda Pharmaceutical Company	Takeda Pharmaceutical Company	United States Patent and Trademark Office	11650159	May 16, 2023
‌ US Patent 7918824 Needled pharmaceutical delivery device with triggered automatic needle insertion and manually controlled pharmaceutical injection	Patent 7918824 was granted and assigned to Eli Lilly on April, 2011 by the United States Patent and Trademark Office.		Eli Lilly	United States Patent and Trademark Office	7918824	April 5, 2011
‌ US Patent 10005827 Double-acylated GLP-1 derivatives	Patent 10005827 was granted and assigned to Novo Nordisk on June, 2018 by the United States Patent and Trademark Office.	Novo Nordisk	Novo Nordisk	United States Patent and Trademark Office	10005827	June 26, 2018
‌ US Patent 7396675 Kit and method for determining a plurality of analytes	Patent 7396675 was granted and assigned to Bayer on July, 2008 by the United States Patent and Trademark Office.		Bayer	United States Patent and Trademark Office	7396675	July 8, 2008
‌ US Patent 11369896 Methods for quantitating individual antibodies from a mixture	Patent 11369896 was granted and assigned to Regeneron Pharmaceuticals on June, 2022 by the United States Patent and Trademark Office.	Regeneron Pharmaceuticals	Regeneron Pharmaceuticals	United States Patent and Trademark Office	11369896	June 28, 2022
‌ US Patent 11571636 Methods for quantitating individual antibodies from a mixture		Regeneron Pharmaceuticals	Regeneron Pharmaceuticals	United States Patent and Trademark Office	11571636	February 7, 2023
‌ US Patent 10335464 Device for titrating basal insulin	Patent 10335464 was granted and assigned to Novo Nordisk on July, 2019 by the United States Patent and Trademark Office.	Novo Nordisk	Novo Nordisk	United States Patent and Trademark Office	10335464	July 2, 2019
‌ US Patent 7500959 Medication delivery system with improved dose accuracy	Patent 7500959 was granted and assigned to Novo Nordisk on March, 2009 by the United States Patent and Trademark Office.		Novo Nordisk	United States Patent and Trademark Office	7500959	March 10, 2009
‌ US Patent 8361036 Injection device having a gearing arrangement	Patent 8361036 was granted and assigned to Novo Nordisk on January, 2013 by the United States Patent and Trademark Office.		Novo Nordisk	United States Patent and Trademark Office	8361036	January 29, 2013

...

Results per page:

13,185 results

0 selected

13,185 results

0 selected